Review ArticleReviews and Commentaries
Benzodiazepine Pharmacology and Central Nervous System–Mediated Effects
Charles E. Griffin, Adam M. Kaye, Franklin Rivera Bueno and Alan D. Kaye
Ochsner Journal June 2013, 13 (2) 214-223;
Charles E. Griffin III
*Department of Anesthesiology, University of Southern California, Los Angeles, CA
MDAdam M. Kaye
†Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, CA
Pharm DFranklin Rivera Bueno
‡Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA
MSAlan D. Kaye
‡Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA
MD, PhDREFERENCES
- ↵
- ↵
- Fox C,
- Liu H,
- Kaye AD
- ↵
- Kelly MD,
- Smith A,
- Banks G,
- et al.
- ↵
- Sieghart W
- ↵
- Rudolph U,
- Crestani F,
- Benke D,
- et al.
- ↵
- Kaufmann WA,
- Humpel C,
- Alheid GF,
- Marksteiner J
- ↵
- Crestani F,
- Löw K,
- Keist R,
- Mandelli M,
- Möhler H,
- Rudolph U
- ↵
- ↵
- Urman RD,
- Kaye AD
- Kaye AD,
- Gayle K,
- Kaye AM
- ↵
- ↵
- Chouinard G,
- Young SN,
- Annable L
- ↵
- ↵
- ↵
- ↵
- Modell JG,
- Lenox RH,
- Weiner S
- ↵
- ↵
- Reves JG,
- Fragen RJ,
- Vinik HR,
- Greenblatt DJ
- ↵
- ↵
- ↵
- ↵
- Kothary SP,
- Brown AC,
- Pandit UA,
- Samra SK,
- Pandit SK
- ↵
- van Rijnsoever C,
- Täuber M,
- Choulli MK,
- et al.
- ↵
- Long DM
- ↵
- Coleman PD,
- Flood DG
- ↵
- MC Rogers,
- Covino BG,
- Tinker JH
- Stiff JL
- ↵
- ↵
- Buffett-Jerrott SE,
- Stewart SH
- ↵
- Negrusz A,
- Juhascik M,
- Gaensslen RE
- ↵
- ↵
- Thomas RE
- ↵
- Verster JC,
- Veldhuijzen DS,
- Volkerts ER
- ↵
- Pisani MA,
- Murphy TE,
- Araujo KL,
- Slattum P,
- Van Ness PH,
- Inouye SK
- ↵
- Ely EW,
- Inouye SK,
- Bernard GR,
- et al.
- McNicoll L,
- Pisani MA,
- Zhang Y,
- Ely EW,
- Siegel MD,
- Inouye SK
- Bergeron N,
- Dubois MJ,
- Dumont M,
- Dial S,
- Skrobik Y
- ↵
- Balas MC,
- Deutschman CS,
- Sullivan-Marx EM,
- Strumpf NE,
- Alston RP,
- Richmond TS
- ↵
- Pisani MA,
- Murphy TE,
- Van Ness PH,
- Araujo KL,
- Inouye SK
In this issue
Benzodiazepine Pharmacology and Central Nervous System–Mediated Effects
Charles E. Griffin, Adam M. Kaye, Franklin Rivera Bueno, Alan D. Kaye
Ochsner Journal Jun 2013, 13 (2) 214-223;
Jump to section
Cited By...
- Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimers disease
- ASD/OCD-Linked Protocadherin-10 Regulates Synapse, But Not Axon, Development in the Amygdala and Contributes to Fear- and Anxiety-Related Behaviors
- Novel Methods for Elucidating Modality Importance in Multimodal Electrophysiology Classifiers
- Impact of Medicare prescription drug (Part D) coverage expansion on utilisation and financial burden of benzodiazepines among older adults: an interrupted time series analysis
- The synthetic cannabinoid dehydroxylcannabidiol restores the function of a major GABAA receptor isoform in a cell model of hyperekplexia
- Photocontrol of endogenous glycine receptors in vivo
- Intermittent catatonia and complex automatisms caused by frontal lobe epilepsy in dementia
- Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma
- Common toxidromes in movement disorder neurology